Global Yeast Infection Market, By Pathogens (Candida Albicans, Candida Glabrata, Candida Rugosa, Others), Types (Vaginal Yeast Infection, Skin Yeast Infection, Throat Yeast Infection, Others), Treatment (Medical Treatment, Surgery), End User (Hospital, Clinics, Ambulatory Centers, Others) – Industry Trends and Forecast to 2029.
Market Analysis and Size
Surging cases of the yeast infection is estimated to drive the market’s growth across the globe. According to NCBI studies, in 2018, around 30%-50% of women had vulvovaginal candidiasis at least once in their lives. Moreover, in Asia Pacific, Candida species is the most frequent yeast infection. Consequently, the market is estimated to show substantial growth over the forecasted period.
Global Yeast infection Market was valued at USD 3.88 billion in 2021 and is expected to reach USD 6.23 billion by 2029, registering a CAGR of 6.10% during the forecast period of 2022-2029. The “bacterial” accounts for the largest pathogen segment in the yeast infection market within the forecasted period owing to the rise in the bacterial yeast infection cases and the rising prevalence of HAIs. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Candidiasis, often known as yeast or fungus infection, is a parasitic ailment. It's a naturally occurring component in the human body. It can cause infection in some cases due to changes in the body's immune level. It can also affect the skin, mouth, and stomach. Yeast infection in the vaginal area is very prevalent among women. Rashes, swelling, redness, stinging, and burning are all symptoms of this infection. Yeast infection can be caused by a lack of immunity, poor cleanliness, or lifestyle disorders.
Report Scope and Market Segmentation
2022 to 2029
2020 (Customizable to 2019 - 2014)
Revenue in USD Billion, Volumes in Units, Pricing in USD
By Pathogens (Candida Albicans, Candida Glabrata, Candida Rugosa, Others), Types (Vaginal Yeast Infection, Skin Yeast Infection, Throat Yeast Infection, Others), Treatment (Medical Treatment, Surgery), End User (Hospital, Clinics, Ambulatory Centers, Others)
U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa
Market Players Covered
Scynexis Inc., (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Astellas Pharma Inc., (Japan), Thermo Fisher Scientific Inc., (U.S.), Novartis AG (Switzerland), Abbott (U.S.), Catalent, Inc., (U.S.), bioMérieux (France), Pfizer Inc. (U.S.), AbbVie Inc., (U.S.), ALLERGAN (Ireland), Jubilant Pharmova Limited (India), Sanofi (France), and AstraZeneca (U.K), Bruker (U.S.), Brundavan Laboratories Ltd. (India), Curia Global, Inc. (U.S.) and Corden Pharma (Germany)
Yeast infection Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
- Growing Prevalence Of Diseases, Infections And Other Ailments
The factors such as the rise in the prevalence of autoimmune disease and yeast infection along with the development of new fungal infections is the most significant factor driving the growth for this market. The rise in the burden of ailments like the cardiovascular, gastrointestinal and other diseases are also expected to accelerate the overall growth of the market.
Furthermore, the improving economic conditions worldwide that enables access to the quality and improved healthcare are also expected to fuel market growth. Moreover, the rising awareness among the patients regarding the yeast infections also cushions the market’s growth within the forecasted period. The rising demand for antifungal drugs and government support for research and development are also projected to bolster the growth of the market.
- Growing Investments and Advancements
Moreover, the financing for the administration of research and development in medical science combined with introduction of new treatment options for yeast infections are estimated to generate lucrative opportunities for the market. The investments in this region for the yeast infection market will further offer numerous growth opportunities for the market.
- Issues Associated with Treatment
On the other hand, issues during treatments and various treatment-related side effects are expected to obstruct market growth.
- Other Limitations
Also, the concerning issues related to the drug resistance for the disorder and the incidents of unmet clinical needs are projected to challenge the yeast infection market in the forecast period of 2022-2029.
This yeast infection market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the yeast infection market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post Covid-19 Impact on Yeast infection Market
Healthcare industry was largely impacted by the outbreak of COVID-19 as financial load on the healthcare industry was enormous. The yeast infection market was largely negatively impacted by the outbreak of COVID-19. The imposition of the lockdown and social distancing restrictions by the government to curb the COVID-19 pandemic outbreak, led to halt of various operations, medicine development and production, supply chain disruptions, stifling business growth, technology event cancellations, suspensions of new developments and has affected the overall production and sales, led to limited industry expansion and financial volatility.
Moreover, the treatment for the yeast infection is hampered. The majority of the doctors are assigned for COVID patient care, according to an orthopedic medical magazine. The clinical drug market, on the other hand, is seeing an increase in research that will lead to various innovations, which will have a positive impact on the market for yeast infections. After COVID-19, the yeast infection market will have a diverse product offering. The market for vaginal yeast infections will increase at the fastest rate.
- In December 2021, Cidara Therapeutics, Inc. and Mundipharma published positive topline data from the key ReSTORE Phase 3 clinical trial, which looked at the efficacy and safety of rezafungin, a once-weekly antifungal candidate, as a first-line treatment for candidemia and invasive candidiasis.
Global Yeast infection Market Scope
The yeast infection market is segmented on the basis of pathogens, types, treatment and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Candida Albicans
- Candida Glabrata
- Candida Rugosa
On the basis of pathogens, the yeast infection market is segmented into candida albicans, candida glabrata, candida rugosa and others.
- Vaginal Yeast Infection
- Skin Yeast Infection
- Throat Yeast Infection
On the basis of types, the yeast infection market is segmented into vaginal yeast infection, skin yeast infection, throat yeast infection and others.
- Medical Treatment
On the basis of treatment, the yeast infection market is bifurcated into medical treatment and surgery.
- Ambulatory Centers
On the basis of end user, the yeast infection market is segmented into hospital, clinics, ambulatory centers, others.
Yeast infection Market Regional Analysis/Insights
The yeast infection market is analyzed and market size insights and trends are provided by country, pathogens, types, treatment and end user as referenced above.
The countries covered in the yeast infection market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the yeast infection market because of the increase in the in yeast infection. Moreover, the rise in the number of cases of vaginal infections within the region.
Europe is expected to witness significant growth during the forecast period of 2022 to 2029 due to the high prevalence of yeast infection within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The yeast infection market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for yeast infection market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the yeast infection market. The data is available for historic period 2010-2020.
Competitive Landscape and Yeast infection Market Share Analysis
The yeast infection market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to yeast infection market.
Some of the major players operating in the yeast infection market are
- Scynexis Inc., (U.S.)
- Merck & Co., Inc. (U.S.)
- Bayer AG (Germany)
- Astellas Pharma Inc., (Japan)
- Thermo Fisher Scientific Inc., (U.S.)
- Novartis AG (Switzerland)
- Abbott (U.S.)
- Catalent, Inc., (U.S.)
- bioMérieux (France)
- Pfizer Inc. (U.S.)
- AbbVie Inc., (U.S.)
- ALLERGAN (Ireland)
- Jubilant Pharmova Limited (India)
- Sanofi (France)
- AstraZeneca (U.K)
- Bruker (U.S.)
- Brundavan Laboratories Ltd. (India)
- Curia Global, Inc. (U.S.)
- Corden Pharma (Germany)